Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is POMALIDOMIDE [ROUTE CODE "PO"], with a corresponding US DMF Number 30408.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 06, 2016, and payment made on August 04, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II